Immediate Impact

5 from Science/Nature 51 standout
Sub-graph 1 of 25

Citing Papers

Targeted therapeutics and novel signaling pathways in non-alcohol-associated fatty liver/steatohepatitis (NAFL/NASH)
2022 Standout
Chronic tissue inflammation and metabolic disease
2021 Standout
7 intermediate papers

Works of Yoichi Inada being referenced

Bezafibrate prevents hepatic stellate cell activation and fibrogenesis in a murine steatohepatitis model, and suppresses fibrogenic response induced by transforming growth factor‐β1 in a cultured stellate cell line
2008
Effects of bezafibrate, PPAR pan-agonist, and GW501516, PPARδ agonist, on development of steatohepatitis in mice fed a methionine- and choline-deficient diet
2006

Author Peers

Author Last Decade Papers Cites
Yoichi Inada 232 56 92 226 101 32 529
Rebecca L. McCullough 212 63 37 239 43 31 564
Tsuneo Ito 145 27 43 300 102 23 532
Dmitri Svistounov 181 16 50 186 119 19 611
Marta Iruarrizaga‐Lejarreta 250 23 63 177 65 22 501
Jinxing Quan 198 40 91 119 61 40 495
H Wobser 130 37 33 333 117 22 534
Hannah K. Drescher 164 38 32 275 90 24 492
Isabel Veloso Alves Pereira 315 21 29 242 61 33 583
Ju Youn Kim 185 113 65 211 41 28 595
Gertrud Schäfer 130 19 60 96 58 27 479

All Works

Loading papers...

Rankless by CCL
2026